{
    "id": 2791,
    "fullName": "IKZF1 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type IKZF1 indicates that no mutation has been detected within the IKZF1 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10320,
        "geneSymbol": "IKZF1",
        "terms": [
            "IKZF1",
            "CVID13",
            "Hs.54452",
            "IK1",
            "IKAROS",
            "LyF-1",
            "LYF1",
            "PPP1R92",
            "PRO0758",
            "ZNFN1A1"
        ]
    },
    "variant": "wild-type",
    "createDate": "12/19/2014",
    "updateDate": "09/06/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1492,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Revlimid (lenalidomide) treatment resulted in IKZF1 degradation and decreased proliferation of multiple myeloma cells in culture (PMID: 24292625).",
            "molecularProfile": {
                "id": 2606,
                "profileName": "IKZF1 wild-type"
            },
            "therapy": {
                "id": 1164,
                "therapyName": "Lenalidomide",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1409,
                    "pubMedId": 24292625,
                    "title": "Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24292625"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2606,
            "profileName": "IKZF1 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}